165 results
Page 8 of 9
6-K
EX-99
46fsuq
28 Feb 12
BioLineRx Announces Receipt of Notice of Allowance from
12:00am
6-K
EX-99.1
hu5z6kfdfa
27 Feb 12
BioLineRx Ltd. Announces Closing of $15 millionPrivate Placement to Institutional Investors
12:00am
6-K
EX-99.2
y5vx2
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-99.1
ob1 iy6vjl5f
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-99
vehfj zk3l
6 Feb 12
Current report (foreign)
12:00am
6-K
EX-99
hm8 4jmwym
23 Jan 12
BioLineRx Signs Exclusive License Agreement
12:00am
6-K
EX-99
no16y23wdka
3 Jan 12
Current report (foreign)
12:00am
6-K
EX-99
tsj1n9mcb
13 Dec 11
BioLineRx to Develop and Commercialize Novel Peptide
12:00am
6-K
EX-99
ojrd636 ytft5vvnc9wo
5 Dec 11
BioLineRx Announces Positive Final Results from Phase Ia
12:00am
6-K
EX-99
gs1imou3ldpqylawv 25
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-1
ou2gi1
21 Nov 11
BioLineRx Announces Receipt of Approval in India
12:00am
6-K
EX-1
6r363bsu4dwcxn7c
26 Sep 11
BioLineRx to Present Data from the Successfully Completed
12:00am
6-K
EX-1
xlj2y
15 Sep 11
BioLineRx to Present at Annual UBS Global Life Sciences
12:00am
6-K
EX-1
gqrkna rgen2asg87t
14 Sep 11
BioLineRx Announces European Confirmation of Medical
12:00am
6-K
EX-1
fj93klilu6z9yyg7rakc
12 Sep 11
BioLineRx Announces Positive Preliminary Results from
12:00am
6-K
EX-1
sjzdx3m46etpan
8 Sep 11
BioLineRx to Present at Annual Rodman and Renshaw
12:00am
6-K
EX-1
nkd9vt9doa fwdb7yg5
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
6-K
EX-1
7bpp8na
23 Aug 11
BioLineRx Reports Second Quarter 2011 Financial Results
12:00am
6-K
EX-2
1wa 3n7owz8
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
20FR12B/A
vzgj45
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am